Integral Health Asset Management’s Edwards Lifesciences EW Stock Holding History

Integral Health Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.5M	Buy	625,000 +455,000	+268%	+$38.1M	2.23%	11
2026 Q1	$13.6M	Sell	170,000 -155,000	-48%	-$12.8M	0.65%	38
2025 Q4	$27.7M	Buy	325,000 +125,000	+63%	+$10.3M	1.38%	22
2025 Q3	$15.6M	Hold	200,000	–	–	1.05%	28
2025 Q2	$15.6M	Buy	200,000 +75,000	+60%	+$5.59M	1.43%	26
2025 Q1	$9.06M	Buy	+125,000	New	+$8.95M	0.96%	30
2024 Q3	–	Sell	-150,000	Closed	-$13.9M	–	77
2024 Q2	$13.9M	Buy	+150,000	New	+$13.3M	1.32%	23
2022 Q1	–	Sell	-45,000	Closed	-$5.83M	–	78
2021 Q4	$5.83M	Buy	45,000 +10,000	+29%	+$1.17M	1.61%	25
2021 Q3	$3.96M	Sell	35,000 -30,000	-46%	-$3.42M	1.14%	35
2021 Q2	$6.73M	Buy	+65,000	New	+$6.13M	1.85%	19
2020 Q4	–	Sell	-30,000	Closed	-$2.4M	–	66
2020 Q3	$2.4M	Buy	+30,000	New	+$2.34M	0.73%	51

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Integral Health Asset Management's EW Position: Q2 2026 in Review

Integral Health Asset Management increased its Edwards Lifesciences (EW) stake by 268% in Q2 2026, buying an estimated $38.1M and bringing the position to 625,000 shares worth $56.5M. The position accounts for 2.23% of the portfolio, ranked #11.

Integral Health Asset Management first reported a position in EW in Q3 2020 and has held it in 11 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Integral Health Asset Management held 625,000 shares of Edwards Lifesciences worth $56.5M as of Q2 2026.
Integral Health Asset Management bought 455,000 Edwards Lifesciences shares in Q2 2026, an estimated $38.1M.
Edwards Lifesciences made up 2.23% of Integral Health Asset Management's portfolio in Q2 2026, its #11 holding.
Integral Health Asset Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 11 quarters since.
1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.